Top Stocks - medical cannabis
Our AI Score combines AI and Alternative data to assess a stock's mid-term market outperformance potential (6+ months) by analyzing multiple financial, technical and alternative data points. This predictive measure assigns a score from 0 to 100, representing the stock's performance and potential.
These are the top stocks in the Medical Cannabis sector / industry.
Company | Price | AI Score | AI Analysis | |
---|---|---|---|---|
![]() |
OrganigramOGI |
$1.75 3.9% |
Sign up | Generate |
![]() |
AltriaMO |
$53.69 1.1% |
Sign up | Generate |
![]() |
Philip Morris InternationalPM |
$125.81 0.5% |
Sign up | Generate |
![]() |
Sundial GrowersSNDL |
$1.98 1% |
Sign up | Generate |
![]() |
TilrayTLRY |
$1.62 3.6% |
Sign up | Generate |
![]() |
Aurora CannabisACB |
$5.41 3.4% |
Sign up | Generate |
![]() |
Cronos GroupCRON |
$2.14 1.4% |
Sign up | Generate |
![]() |
Canopy GrowthCGC |
$4.48 5.5% |
Sign up | Generate |
What are the top stocks in the Medical Cannabis sector / industry to buy today?
As of the latest update, some of the top stocks in the Medical Cannabis sector / industry include Organigram (OGI), Altria (MO), and Philip Morris International (PM). These stocks, with their high AI scores, serve as a buy signal for investors looking for potential outperformance in the market. Always do your own research.
What makes AltIndex's top stocks in the Medical Cannabis sector / industry unique?
AltIndex combines financial, technical and alternative data to assess a stock's mid-term market outperformance potential over the next 6+ months. By analyzing thousands of data points, this predictive measure assigns a score from 0 to 100, representing the stock's performance and potential, making our list unique for investors.
How often are the top stocks in the Medical Cannabis sector / industry updated on AltIndex?
We update the AI score, the underlying score for our top stocks, daily. This ensures that our recommendations reflect the most current market trends and data, helping investors make informed decisions with the latest information.